Precigen (PGEN) Return on Invested Capital (2014 - 2026)
Precigen (PGEN) reported Return on Invested Capital of 0.01% for Q1 2026, up 10.0% year-over-year from 0.01% in Q1 2025, and up 7.19% quarter-over-quarter from 0.01% in Q4 2025.
Precigen (PGEN) Return on Invested Capital (2014 - 2026) Analysis & Trends
Precigen (PGEN) has 13 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- Return on Invested Capital for Q1 2026 came in at 0.01%, up 10.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 10.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
- Return on Invested Capital rose to 0.01% in Q1 2026 per PGEN's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.04% in Q2 2025 and troughed at 0.11% in Q1 2025.
- A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2025 and 2026: Return on Invested Capital retreated 10 bps in 2025, then increased 10 bps in 2026.
- A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then plunged by 95 bps to 0.01% in 2023, then tumbled by 280 bps to 0.03% in 2024, then soared by 69 bps to 0.01% in 2025, then grew by 7 bps to 0.01% in 2026.
- Business Quant data shows PGEN's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.01% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -0.01% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Precigen | 1.32 Bn | 1.32 Bn | 20.69 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | 0.04% |
| Mar 31, 2025 | -0.11% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.03% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |